Compile Data Set for Download or QSAR
Report error Found 87 Enz. Inhib. hit(s) with all data for entry = 12737
TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724424(Synthesis of N-(2-(5-oxo-2-((pyridin-3-ylmethyl)am...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724422(Synthesis of N-(2-(2-(((4-methylpyridin-3-yl)methy...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724463(N-(2-(2-((2-fluoro-4-methylbenzyl)amino)-5-oxo-5,7...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724431(N-(2-(2-((2,4-difluorobenzyl)amino)-5-oxo-5,7-dihy...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724464(Synthesis of N-(2-(2-((2,4-difluorobenzyl)amino)-5...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724461(N-(2-(2-((4-chloro-2-fluorobenzyl)amino)-5-oxo-5,7...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724462(N-(2-(2-((4-chloro-2,6-difluorobenzyl)amino)-5-oxo...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724428(N-(2-(2-((2,4-difluorobenzyl)amino)-5-oxo-5,7-dihy...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724439(US20250066353, Compound 69)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724440(US20250066353, Compound 70)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724437(N-(2-(2-(((4,6-dimethylpyridin-3-yl)methyl)amino)-...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724469(Synthesis of N-(2-(2-((4-chloro-2,6-difluorobenzyl...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724467(Synthesis of N-(2-(5-oxo-2-((2,4,6-trifluorobenzyl...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724468(Synthesis of N-(2-(2-((4-chloro-2,6-difluorobenzyl...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724465(Synthesis of N-(2-(5-oxo-2-((2,4,6-trifluorobenzyl...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724401(Synthesis of N-(2-(2-(((6-methylpyridin-3-yl)methy...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724466(Synthesis of N-(2-(2-((2,4-difluorobenzyl)amino)-5...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724414(Synthesis of N-(2-(5-oxo-2-((2,4,6-trifluorobenzyl...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724443(N-(2-(5-oxo-2-((2,4,6-trifluorobenzyl)amino)-5,7-d...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724411(Synthesis of N-(2-(2-(((6-methylpyridin-3-yl)methy...)
Affinity DataIC50: 25.5nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724455(N-(2-(2-((3-fluorobenzyl)amino)-5-oxo-5,7-dihydro-...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724391(Synthesis of N-(2-(5-Oxo-2-((pyridin-3-ylmethyl)am...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724456(N-(2-(2-((3-fluorobenzyl)amino)-5-oxo-5,7-dihydro-...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724453(N-(2-(2-((2-methylbenzyl)amino)-5-oxo-5,7-dihydro-...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724454(N-(2-(2-((2-methylbenzyl)amino)-5-oxo-5,7-dihydro-...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724451(N-(2-(2-((5-fluoro-2-methylbenzyl)amino)-5-oxo-5,7...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724387(Synthesis of 6-(3,5-Dimethylbenzyl)-2-((pyridin-3-...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724452(N-(2-(2-((5-fluoro-2-methylbenzyl)amino)-5-oxo-5,7...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724449(N-(2-(2-((2-chloro-4-fluorobenzyl)amino)-5-oxo-5,7...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724450(N-(2-(2-((2-chloro-4-fluorobenzyl)amino)-5-oxo-5,7...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724400(Synthesis of (S)—N-(2-(5-oxo-2-((1-(pyridin-3-yl)e...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724397(Synthesis of N-(2-(5-oxo-2-((pyridin-2-ylmethyl)am...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724459(N-(2-(2-(((2-methylpyridin-3-yl)methyl)amino)-5-ox...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724395(US20250066353, Compound 18)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724460(N-(2-(5-oxo-2-((2,4,6-trifluorobenzyl)amino)-5,7-d...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724457(N-(2-(2-(((6-methylpyridin-3-yl)methyl)amino)-5-ox...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724458(N-(2-(2-(((4-methylpyridin-3-yl)methyl)amino)-5-ox...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724438(N-(2-(5-oxo-2-(((4-(trifluoromethyl)pyridin-3-yl)m...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724435(N-(2-(2-(((2-methylpyridin-3-yl)methyl)amino)-5-ox...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724436(N-(2-(2-(((2-methylpyridin-3-yl)methyl)amino)-5-ox...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724433(N-(2-(2-(((5-methylpyridin-3-yl)methyl)amino)-5-ox...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724434(N-(2-(2-(((5-methylpyridin-3-yl)methyl)amino)-5-ox...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724447(N-(2-(2-((4-fluoro-2-methylbenzyl)amino)-5-oxo-5,7...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724445(N-(2-(5-oxo-2-((2,3,4-trifluorobenzyl)amino)-5,7-d...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724446(N-(2-(5-oxo-2-((2,3,4-trifluorobenzyl)amino)-5,7-d...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724423(Synthesis of N-(2-(5-oxo-2-((pyrazin-2-ylmethyl)am...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724421(Synthesis of 2,2,2-trifluoro-N-(2-(5-oxo-2-((pyrid...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724419(Synthesis of N-(2-(5-oxo-2-((pyridin-3-ylmethyl)am...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724432(N-(2-(5-oxo-2-((2,4,5-trifluorobenzyl)amino)-5,7-d...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPantetheinase(Human)
Athos Therapeutics

US Patent
LigandPNGBDBM724429(N-(2-(5-oxo-2-((2,4,5-trifluorobenzyl)amino)-5,7-d...)
Affinity DataIC50: 525nMAssay Description:5 μL of 3× (45 μM) of Pantothenate-AMC to achieve final concentrations of 15 μM (0.25% DMSO final) were added in a 384 well assay plate followed by t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

Displayed 1 to 50 (of 87 total ) | Next | Last >>
Jump to: